Results 11 to 20 of about 447,676 (385)
Autoimmune hemolytic anemia: current knowledge and perspectives [PDF]
Immunity & Ageing, 2020 Autoimmune hemolytic anemia (AIHA) is an acquired, heterogeneous group of diseases which includes warm AIHA, cold agglutinin disease (CAD), mixed AIHA, paroxysmal cold hemoglobinuria and atypical AIHA.
Sylwia Sulimiera Michalak +5 more
openalex +2 more sources
BMC Pharmacology and Toxicology, 2018 Background Drug induced immune hemolytic anemia (DIIHA) is a rare complication and often underdiagnosed. DIIHA is frequently associated with a bad outcome, including organ failure and even death. For the last decades, ceftriaxone has been one of the most
Hans Benno Leicht +5 more
doaj +2 more sources
How I treat warm autoimmune hemolytic anemia.
Blood, 2021 Warm autoimmune hemolytic anemia (wAIHA) is caused by increased erythrocyte destruction by IgG autoantibodies, with or without complement activation.
W. Barcellini, B. Fattizzo
semanticscholar +1 more source
Annals of Hematology, 2022 COVID-19 is a global pandemic triggered by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 entry point involves the interaction with angiotensin-converting enzyme 2 (ACE2) receptor, CD147, and erythrocyte Band3 protein ...
H. Al-kuraishy +4 more
semanticscholar +1 more source
Autoimmune hemolytic anemia: causes and consequences
Expert Review of Clinical Immunology, 2022 Introduction Autoimmune hemolytic anemia (AIHA) is classified according to the direct antiglobulin test (DAT) and thermal characteristics of the autoantibody into warm and cold forms, and in primary versus secondary depending on the presence of ...
B. Fattizzo, W. Barcellini
semanticscholar +1 more source
How I treat microangiopathic hemolytic anemia in patients with cancer
Blood, 2021 Diagnosis and treatment of acquired hemolytic anemia can be challenging. In this How I Treat series, edited by Mario Cazzola, clinical experts discuss their approaches to the treatment of patients with 4 different classes of acquired hemolytic anemia.
M. Thomas, M. Scully
semanticscholar +1 more source
Autoimmune Hemolytic Anemia in the Pediatric Setting
Journal of Clinical Medicine, 2021 Autoimmune hemolytic anemia (AIHA) is a rare disease in children, presenting with variable severity. Most commonly, warm-reactive IgG antibodies bind erythrocytes at 37 °C and induce opsonization and phagocytosis mainly by the splenic macrophages ...
Aikaterini Voulgaridou, T. Kalfa
semanticscholar +1 more source
Hemolytic Anemia Complicating COVID-19 Infection
Journal of Hematology, 2021 Coronavirus disease 2019 (COVID-19) has been associated with a spectrum of reported hematological complications ranging from immune cytopenias to thromboembolic manifestations of coagulopathy.
Abeer N. Abouyabis, Grace Thompson Bell
semanticscholar +1 more source
PLoS ONE, 2022 BackgroundImmune hemolytic anemia commonly affects human immune deficiency infected individuals. Among anemic HIV patients in Africa, the burden of IHA due to autoantibody was ranged from 2.34 to 3.06 due to drug was 43.4%.
Samuel Sahile Kebede +5 more
doaj +2 more sources
Cefazolin-induced hemolytic anemia: a case report and systematic review of literature
European Journal of Medical Research, 2021 Background Cefazolin is a first-generation cephalosporin commonly used for skin and soft tissue infections, abdominal and orthopedic surgery prophylaxis, and methicillin-sensitive staph aureus.
Elizabeth Mause +2 more
doaj +1 more source